Single-Cell Genome Sequencing Market 2027 By Product, Technology, Workflow, Disease Indication, Application, End User and Geography | The Insight Partners

Single-Cell Genome Sequencing (SCGS) Market to 2027 - Global Analysis and Forecasts By Product (Instruments and Reagents); Technology (Multiple Displacement Amplification (MDA), Microarray, Polymerase Chain Reaction (PCR), Quantitative PCR (qPCR), and Sequencing); Workflow (Genomic Analysis, Sample Preparation and Single Cell Isolation); Disease Indication (Cancer, Immunology, Microbiology, Neurobiology, Prenatal Diagnosis, and Other Diseases); Application (Cell Differentiation/Reprogramming, Circulating Cells, Genomic Variation, Subpopulation Characterization, and Other Applications); End User (Academic & Research Laboratories, Biotechnology & Biopharmaceutical Companies, Clinics, and Other End Users) and Geography

Report Code: TIPRE00006701 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Single-cell genome sequencing includes the isolation of a single cell, to amplify as well as sequence the genes that are present within a single cell. The technique aims to enable a better understanding of complex microbial ecosystems and diseases in multicellular organisms. The use of single-cell genome sequencing is expected to increase significantly since they help in revealing molecular changes that play a vital role in carcinogenesis, interactions with the host immune system, and metastasis.

MARKET DYNAMICS

The single-cell genome sequencing (SCGS) market is anticipated to grow in the forecast, owing to the rising prevalence of chronic disease along with an increase in the number of autoimmune disorders. Also, favorable government policies and funding schemes are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Single-Cell Genome Sequencing (SCGS) Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of single-cell genome sequencing (SCGS) market with detailed market segmentation by product, technology, workflow, disease indication, application, end user and geography. The global single-cell genome sequencing (SCGS) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading single-cell genome sequencing (SCGS) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global single-cell genome sequencing (SCGS) market is segmented on the basis of product, technology, workflow, disease indication, application, and end user. Based on product, the market is classified as, instruments and reagents. On the basis of technology, the market is categorized as, multiple displacement amplification (MDA), microarray, polymerase chain reaction (PCR), quantitative pcr (qPCR), and sequencing. The single-cell genome sequencing (SCGS) market based on workflow is categorized as, genomic analysis, sample preparation and single cell isolation. On the basis of disease indication, the market is segmented as, cancer, immunology, microbiology, neurobiology, prenatal diagnosis, and other diseases. The single-cell genome sequencing (SCGS) market is categorized based on application such as, cell differentiation/reprogramming, circulating cells, genomic variation, subpopulation characterization, and other applications. Similarly, on the basis of end user, the market is segmented as, academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and other end users.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global single-cell genome sequencing (SCGS) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The single-cell genome sequencing (SCGS) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting single-cell genome sequencing (SCGS) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the single-cell genome sequencing (SCGS) market in these regions.


MARKET PLAYERS


The report covers key developments in the single-cell genome sequencing (SCGS) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from single-cell genome sequencing (SCGS) market are anticipated to have lucrative growth opportunities in the future with the rising demand for single-cell genome sequencing (SCGS) market in the global market. Below mentioned is the list of few companies engaged in the single-cell genome sequencing (SCGS) market.

The report also includes the profiles of key single-cell genome sequencing (SCGS) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  10x Genomics
  •  BD
  •  BGI
  •  Bio-Rad Laboratories, Inc.
  •  Fluidigm
  •  Novogene Corporation
  •  Oxford Nanopore Technologies
  •  QIAGEN
  •  Takara Bio Inc.
  •  Thermo Fisher Scientific Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Single-Cell Genome Sequencing (SCGS) Market - By Product
1.3.2 Single-Cell Genome Sequencing (SCGS) Market - By Technology
1.3.3 Single-Cell Genome Sequencing (SCGS) Market - By Workflow
1.3.4 Single-Cell Genome Sequencing (SCGS) Market - By Disease Indication
1.3.5 Single-Cell Genome Sequencing (SCGS) Market - By Application
1.3.6 Single-Cell Genome Sequencing (SCGS) Market - By End User
1.3.7 Single-Cell Genome Sequencing (SCGS) Market - By Region
1.3.7.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - GLOBAL MARKET ANALYSIS
6.1. SINGLE-CELL GENOME SEQUENCING (SCGS) - GLOBAL MARKET OVERVIEW
6.2. SINGLE-CELL GENOME SEQUENCING (SCGS) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2027 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. REAGENTS
7.4.1. Overview
7.4.2. Reagents Market Forecast and Analysis

8. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2027 – TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. MULTIPLE DISPLACEMENT AMPLIFICATION (MDA)
8.3.1. Overview
8.3.2. Multiple Displacement Amplification (MDA) Market Forecast and Analysis
8.4. MICROARRAY
8.4.1. Overview
8.4.2. Microarray Market Forecast and Analysis
8.5. POLYMERASE CHAIN REACTION (PCR)
8.5.1. Overview
8.5.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
8.6. QUANTITATIVE PCR (QPCR)
8.6.1. Overview
8.6.2. Quantitative PCR (qPCR) Market Forecast and Analysis
8.7. SEQUENCING
8.7.1. Overview
8.7.2. Sequencing Market Forecast and Analysis

9. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2027 – WORKFLOW
9.1. OVERVIEW
9.2. WORKFLOW MARKET FORECASTS AND ANALYSIS
9.3. GENOMIC ANALYSIS
9.3.1. Overview
9.3.2. Genomic Analysis Market Forecast and Analysis
9.4. SAMPLE PREPARATION
9.4.1. Overview
9.4.2. Sample Preparation Market Forecast and Analysis
9.5. SINGLE CELL ISOLATION
9.5.1. Overview
9.5.2. Single Cell Isolation Market Forecast and Analysis

10. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2027 – DISEASE INDICATION
10.1. OVERVIEW
10.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.4. IMMUNOLOGY
10.4.1. Overview
10.4.2. Immunology Market Forecast and Analysis
10.5. MICROBIOLOGY
10.5.1. Overview
10.5.2. Microbiology Market Forecast and Analysis
10.6. NEUROBIOLOGY
10.6.1. Overview
10.6.2. Neurobiology Market Forecast and Analysis
10.7. PRENATAL DIAGNOSIS
10.7.1. Overview
10.7.2. Prenatal diagnosis Market Forecast and Analysis
10.8. OTHER DISEASES
10.8.1. Overview
10.8.2. Other Diseases Market Forecast and Analysis

11. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2027 – APPLICATION
11.1. OVERVIEW
11.2. APPLICATION MARKET FORECASTS AND ANALYSIS
11.3. CELL DIFFERENTIATION/REPROGRAMMING
11.3.1. Overview
11.3.2. Cell Differentiation/Reprogramming Market Forecast and Analysis
11.4. CIRCULATING CELLS
11.4.1. Overview
11.4.2. Circulating Cells Market Forecast and Analysis
11.5. GENOMIC VARIATION
11.5.1. Overview
11.5.2. Genomic Variation Market Forecast and Analysis
11.6. SUBPOPULATION CHARACTERIZATION
11.6.1. Overview
11.6.2. Subpopulation Characterization Market Forecast and Analysis
11.7. OTHER APPLICATIONS
11.7.1. Overview
11.7.2. Other Applications Market Forecast and Analysis

12. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2027 – END USER
12.1. OVERVIEW
12.2. END USER MARKET FORECASTS AND ANALYSIS
12.3. ACADEMIC & RESEARCH LABORATORIES
12.3.1. Overview
12.3.2. Academic & Research Laboratories Market Forecast and Analysis
12.4. BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES
12.4.1. Overview
12.4.2. Biotechnology & Biopharmaceutical Companies Market Forecast and Analysis
12.5. CLINICS
12.5.1. Overview
12.5.2. Clinics Market Forecast and Analysis
12.6. OTHER END USERS
12.6.1. Overview
12.6.2. Other End Users Market Forecast and Analysis

13. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Single-Cell Genome Sequencing (SCGS) Market Overview
13.1.2 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.1.3 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.1.4 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.1.5 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.1.6 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.1.7 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.1.8 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.1.9 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.1.9.1 United States Single-Cell Genome Sequencing (SCGS) Market
13.1.9.1.1 United States Single-Cell Genome Sequencing (SCGS) Market by Product
13.1.9.1.2 United States Single-Cell Genome Sequencing (SCGS) Market by Technology
13.1.9.1.3 United States Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.1.9.1.4 United States Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.1.9.1.5 United States Single-Cell Genome Sequencing (SCGS) Market by Application
13.1.9.1.6 United States Single-Cell Genome Sequencing (SCGS) Market by End User
13.1.9.2 Canada Single-Cell Genome Sequencing (SCGS) Market
13.1.9.2.1 Canada Single-Cell Genome Sequencing (SCGS) Market by Product
13.1.9.2.2 Canada Single-Cell Genome Sequencing (SCGS) Market by Technology
13.1.9.2.3 Canada Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.1.9.2.4 Canada Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.1.9.2.5 Canada Single-Cell Genome Sequencing (SCGS) Market by Application
13.1.9.2.6 Canada Single-Cell Genome Sequencing (SCGS) Market by End User
13.1.9.3 Mexico Single-Cell Genome Sequencing (SCGS) Market
13.1.9.3.1 Mexico Single-Cell Genome Sequencing (SCGS) Market by Product
13.1.9.3.2 Mexico Single-Cell Genome Sequencing (SCGS) Market by Technology
13.1.9.3.3 Mexico Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.1.9.3.4 Mexico Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.1.9.3.5 Mexico Single-Cell Genome Sequencing (SCGS) Market by Application
13.1.9.3.6 Mexico Single-Cell Genome Sequencing (SCGS) Market by End User
13.2. EUROPE
13.2.1 Europe Single-Cell Genome Sequencing (SCGS) Market Overview
13.2.2 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.2.3 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.2.4 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.2.5 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.2.6 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.2.7 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.2.8 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.2.9 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Single-Cell Genome Sequencing (SCGS) Market
13.2.9.1.1 Germany Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.1.2 Germany Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.1.3 Germany Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.1.4 Germany Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.1.5 Germany Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.1.6 Germany Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.2 France Single-Cell Genome Sequencing (SCGS) Market
13.2.9.2.1 France Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.2.2 France Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.2.3 France Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.2.4 France Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.2.5 France Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.2.6 France Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.3 Italy Single-Cell Genome Sequencing (SCGS) Market
13.2.9.3.1 Italy Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.3.2 Italy Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.3.3 Italy Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.3.4 Italy Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.3.5 Italy Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.3.6 Italy Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.4 Spain Single-Cell Genome Sequencing (SCGS) Market
13.2.9.4.1 Spain Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.4.2 Spain Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.4.3 Spain Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.4.4 Spain Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.4.5 Spain Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.4.6 Spain Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.5 United Kingdom Single-Cell Genome Sequencing (SCGS) Market
13.2.9.5.1 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.5.2 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.5.3 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.5.4 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.5.5 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.5.6 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by End User
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Overview
13.3.2 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.3.3 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.3.4 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.3.5 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.3.6 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.3.7 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.3.8 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.3.9 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Single-Cell Genome Sequencing (SCGS) Market
13.3.9.1.1 Australia Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.1.2 Australia Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.1.3 Australia Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.1.4 Australia Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.1.5 Australia Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.1.6 Australia Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.2 China Single-Cell Genome Sequencing (SCGS) Market
13.3.9.2.1 China Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.2.2 China Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.2.3 China Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.2.4 China Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.2.5 China Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.2.6 China Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.3 India Single-Cell Genome Sequencing (SCGS) Market
13.3.9.3.1 India Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.3.2 India Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.3.3 India Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.3.4 India Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.3.5 India Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.3.6 India Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.4 Japan Single-Cell Genome Sequencing (SCGS) Market
13.3.9.4.1 Japan Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.4.2 Japan Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.4.3 Japan Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.4.4 Japan Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.4.5 Japan Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.4.6 Japan Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.5 South Korea Single-Cell Genome Sequencing (SCGS) Market
13.3.9.5.1 South Korea Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.5.2 South Korea Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.5.3 South Korea Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.5.4 South Korea Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.5.5 South Korea Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.5.6 South Korea Single-Cell Genome Sequencing (SCGS) Market by End User
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Overview
13.4.2 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.4.3 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.4.4 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.4.5 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.4.6 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.4.7 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.4.8 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.4.9 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Single-Cell Genome Sequencing (SCGS) Market
13.4.9.1.1 South Africa Single-Cell Genome Sequencing (SCGS) Market by Product
13.4.9.1.2 South Africa Single-Cell Genome Sequencing (SCGS) Market by Technology
13.4.9.1.3 South Africa Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.4.9.1.4 South Africa Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.4.9.1.5 South Africa Single-Cell Genome Sequencing (SCGS) Market by Application
13.4.9.1.6 South Africa Single-Cell Genome Sequencing (SCGS) Market by End User
13.4.9.2 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market
13.4.9.2.1 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Product
13.4.9.2.2 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Technology
13.4.9.2.3 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.4.9.2.4 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.4.9.2.5 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Application
13.4.9.2.6 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by End User
13.4.9.3 U.A.E Single-Cell Genome Sequencing (SCGS) Market
13.4.9.3.1 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Product
13.4.9.3.2 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Technology
13.4.9.3.3 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.4.9.3.4 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.4.9.3.5 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Application
13.4.9.3.6 U.A.E Single-Cell Genome Sequencing (SCGS) Market by End User
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Single-Cell Genome Sequencing (SCGS) Market Overview
13.5.2 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.5.3 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.5.4 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.5.5 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.5.6 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.5.7 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.5.8 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.5.9 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Single-Cell Genome Sequencing (SCGS) Market
13.5.9.1.1 Brazil Single-Cell Genome Sequencing (SCGS) Market by Product
13.5.9.1.2 Brazil Single-Cell Genome Sequencing (SCGS) Market by Technology
13.5.9.1.3 Brazil Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.5.9.1.4 Brazil Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.5.9.1.5 Brazil Single-Cell Genome Sequencing (SCGS) Market by Application
13.5.9.1.6 Brazil Single-Cell Genome Sequencing (SCGS) Market by End User
13.5.9.2 Argentina Single-Cell Genome Sequencing (SCGS) Market
13.5.9.2.1 Argentina Single-Cell Genome Sequencing (SCGS) Market by Product
13.5.9.2.2 Argentina Single-Cell Genome Sequencing (SCGS) Market by Technology
13.5.9.2.3 Argentina Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.5.9.2.4 Argentina Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.5.9.2.5 Argentina Single-Cell Genome Sequencing (SCGS) Market by Application
13.5.9.2.6 Argentina Single-Cell Genome Sequencing (SCGS) Market by End User

14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

15. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET, KEY COMPANY PROFILES
15.1. 10X GENOMICS
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. BD
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. BGI
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. BIO-RAD LABORATORIES, INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. FLUIDIGM
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. NOVOGENE CORPORATION
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. OXFORD NANOPORE TECHNOLOGIES
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. QIAGEN
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. TAKARA BIO INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. THERMO FISHER SCIENTIFIC INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
The List of Companies

1. 10x Genomics
2. BD
3. BGI
4. Bio-Rad Laboratories, Inc.
5. Fluidigm
6. Novogene Corporation
7. Oxford Nanopore Technologies
8. QIAGEN
9. Takara Bio Inc.
10. Thermo Fisher Scientific Inc.